Skip to main content
. Author manuscript; available in PMC: 2014 Dec 16.
Published in final edited form as: Nucl Med Biol. 2013 May 20;40(6):788–794. doi: 10.1016/j.nucmedbio.2013.04.006

Fig. 2.

Fig. 2

Biodistribution data. (A) Tissue distribution of 99mTc-NC100692 in mice bearing subcutaneous U87MG tumors (percent injected dose per gram, %ID/g; n = 5/6). Tumor uptake peaked at around 30–60 min. (B) Biodistribution of 99mTc-labeled non-specific structural analogue of NC100692 at 60 min post-injection (n = 5). (C) Effect of blocking uptake with excess mass of NC100692; biodistribution at 30 min post-injection of 99mTc-NC100692 preceded by saline control (filled bars), and preceded by 2000-fold mass of unlabeled NC100692 (unfilled bars) (n = 4/5). The same y-axes are used for ease of comparison.